¼¼°èÀÇ À¯ÀüÀÚÇü ºÐ¼® ½ÃÀå º¸°í¼­(2025³â)
Genotyping Assay Global Market Report 2025
»óǰÄÚµå : 1686482
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯ÀüÀÚÇü ºÐ¼® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ºñ¾àÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¸ÂÃãÈ­ ¹× °³ÀÎÈ­, °Ç°­ ¹× À£´Ï½º Æ®·»µå, ÀÌÄ¿¸Ó½º ¼ºÀå, ½º¸¶Æ® ¹× ±â´É¼º À¯¸® Á¦Ç°, ¿ä¸® ¹× È¥ÇÕ Æ®·»µå¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä Æ®·»µå·Î´Â Àç·á Çõ½Å, Çõ½ÅÀûÀÎ ÇüÅ ¹× µðÀÚÀÎ, ½º¸¶Æ® À¯¸® Á¦Ç°, À½·á¿ë Ư¼ö À¯¸® Á¦Ç°, °Ç°­ ¹× ¾ÈÀü ±â´É µîÀÌ ÀÖ½À´Ï´Ù.

À¯Àü¼º Áúȯ Áõ°¡°¡ À¯ÀüÀÚÇü ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.À¯ÀüÀÚ ÁúȯÀº °³ÀÎÀÇ DNAÀÇ ÀÌ»óÀ̳ª º¯ÀÌ¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÚ¼±´Üü ÁøÇÇÇÃÀº 2023³â 6¿ù ¿µ±¹ ¾î¸°ÀÌÀÇ ¾à 25¸í Áß 1¸íÀÌ À¯Àü¼º ÁúȯÀ» °®°í ¸Å³â ¾à 3¸¸¸íÀÇ ½Å»ý¾Æ¿Í À¯¾Æ°¡ ¿µÇâÀ» ¹ÞÀ¸¸ç 240¸¸¸í ÀÌ»óÀÇ ¾ÆÀ̵é°ú ¼ºÀÎÀÌ ¿µÇâÀ» ¹Þ¾Ò´Ù°í º¸°íÇß½À´Ï´Ù. µû¶ó¼­ À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â À¯ÀüÀÚÇü ºÐ¼® ½ÃÀåÀÇ È®´ë¿¡ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù.

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ ¶ÇÇÑ À¯ÀüÀÚÇü ºÐ¼® ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¸ÂÃãÇü ÀÇ·á´Â °³ÀΠƯÀ¯ÀÇ À¯ÀüÀÚ ±¸¼º¿¡ ¸ÂÃá Ä¡·á¸¦ ½Ç½ÃÇØ, º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ ÇコÄÉ¾î °³ÀÔÀ» Á¦°øÇÏ´Â °ÍÀÔ´Ï´Ù. 2023³â 1¿ù, ½ÄǰÀǾ౹(FDA)Àº 2022³â¿¡ ½ÂÀÎµÈ 35°³ÀÇ Ä¡·á¿ë ºÐÀÚ ÀǾàǰ(NME) Áß ¾à 34%(12°³)°¡ ÀǷῬÇÕ(PMC)¿¡ µû¶ó¼­ °³º°È­ ÀǾàǰÀ¸·Î ºÐ·ùµÇ¾ú´Ù°í º¸°íÇß½À´Ï´Ù.À̰ÍÀº ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡¸¦ ºÎ°¢Çϰí ÀÖ¾î, À¯ÀüÀÚÇü ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A genotyping assay is a laboratory technique or method employed to determine an individual's genetic makeup at specific genetic loci or positions within their DNA. It involves the identification and analysis of genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions and deletions, present in an individual's genome.

The primary products and services in the genotyping assay market include reagents and kits, genotyping services, instruments, and bioinformatics. Reagents and kits serve as crucial components in various scientific and laboratory processes, especially in fields such as molecular biology, chemistry, and diagnostics. Various technologies are employed in genotyping assays, including microarrays, polymerase chain reaction, sequencing, capillary electrophoresis, matrix-assisted laser desorption or ionization-time of flight mass spectrometry, and others. These technologies cater to diverse end-users such as pharmacogenomics, personalized medicine and diagnostics, animal genetics, agricultural biotechnology, research and diagnostic laboratories, and academic institutes.

The genotyping assay market research report is one of a series of new reports from The Business Research Company that provides genotyping assay market statistics, including genotyping assay industry global market size, regional shares, competitors with a genotyping assay market share, detailed genotyping assay market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping assay industry. This genotyping assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genotyping assay market size has grown exponentially in recent years. It will grow from $33.98 billion in 2024 to $41.6 billion in 2025 at a compound annual growth rate (CAGR) of 22.4%. The growth in the historic period can be attributed to traditional glassware usage, cultural and lifestyle influences, economic factors, hospitality and foodservice industry growth, gift and decor trends.

The genotyping assay market size is expected to see exponential growth in the next few years. It will grow to $95.5 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to customization and personalization, health and wellness trends, e-commerce growth, smart and functional glassware, culinary and mixology trends. Major trends in the forecast period include material innovation, innovative shapes and designs, smart glassware, specialized glassware for beverages, health and safety features.

The increasing prevalence of genetic disorders is expected to drive the growth of the genotyping assay market. Genetic disorders result from abnormalities or mutations in an individual's DNA. Genotyping assays play a crucial role in identifying and analyzing these genetic variations, enabling the detection of specific mutations or variations associated with particular genetic disorders. For example, Gene People, a UK-based charity organization, reported in June 2023 that approximately one in every 25 children in the UK had a genetic disorder, affecting around 30,000 newborns and young children annually, along with more than 2.4 million children and adults. Hence, the growing prevalence of genetic disorders is a significant factor contributing to the expansion of the genotyping assay market.

The rising demand for personalized medicine is another key driver for the growth of the genotyping assay market. Personalized medicine involves tailoring medical treatment to an individual's unique genetic makeup, offering more precise and effective healthcare interventions. Genotyping assays are essential in personalized medicine to analyze an individual's genetic profile, enabling customized drug selection and dosage. In January 2023, the Food and Drug Administration (FDA) reported that out of the 35 therapeutic new molecular entities (NMEs) approved in 2022, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the increasing demand for personalized medicine, which, in turn, is propelling the growth of the genotyping assay market.

Key players in the genotyping assay market are actively advancing genomic research, such as the development of CE-IVD marked assays to detect treatment-resistant strains of HIV-1. An example is the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit by Thermo Fisher Scientific, launched in January 2023. This Sanger sequencing-based assay examines HIV-positive samples to identify genetic variants resistant to common antiretroviral therapeutics. The kit's unique features include assessing genomic mutations, utilizing HIV RNA, detecting drug resistance mutations through gold-standard Sanger sequencing technology, and being designed for clinical use. This product launch adds value by enhancing the detection of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, meeting regulatory requirements, exhibiting high-performance characteristics, and being compatible with existing sequencing platforms and workflows.

In August 2023, Transnetyx Inc., a US-based biotechnology company, acquired Laragen Inc. for an undisclosed sum. Through this acquisition, Transnetyx aims to broaden its solutions by incorporating sequencing and next-generation sequencing (NGS) services, offering large research institutes improved access to cutting-edge genetic services. Laragen Inc., also based in the US, specializes in providing sequencing and genotyping assay services for DNA.

Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genotyping assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genotyping assay market includes revenues earned by entities that provide genotyping assay services such as single nucleotide polymorphisms (SNPs) genotyping, short tandem repeats (STRs) genotyping, whole genome genotyping, and clinical genotyping services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping assay market consists of sales of products such as polymerase chain reaction (PCR) primers, SNP genotyping kits, DNA extraction kits, and microarray chips. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genotyping Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genotyping assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genotyping assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genotyping assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Genotyping Assay Market Characteristics

3. Genotyping Assay Market Trends And Strategies

4. Genotyping Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genotyping Assay Growth Analysis And Strategic Analysis Framework

6. Genotyping Assay Market Segmentation

7. Genotyping Assay Market Regional And Country Analysis

8. Asia-Pacific Genotyping Assay Market

9. China Genotyping Assay Market

10. India Genotyping Assay Market

11. Japan Genotyping Assay Market

12. Australia Genotyping Assay Market

13. Indonesia Genotyping Assay Market

14. South Korea Genotyping Assay Market

15. Western Europe Genotyping Assay Market

16. UK Genotyping Assay Market

17. Germany Genotyping Assay Market

18. France Genotyping Assay Market

19. Italy Genotyping Assay Market

20. Spain Genotyping Assay Market

21. Eastern Europe Genotyping Assay Market

22. Russia Genotyping Assay Market

23. North America Genotyping Assay Market

24. USA Genotyping Assay Market

25. Canada Genotyping Assay Market

26. South America Genotyping Assay Market

27. Brazil Genotyping Assay Market

28. Middle East Genotyping Assay Market

29. Africa Genotyping Assay Market

30. Genotyping Assay Market Competitive Landscape And Company Profiles

31. Genotyping Assay Market Other Major And Innovative Companies

32. Global Genotyping Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genotyping Assay Market

34. Recent Developments In The Genotyping Assay Market

35. Genotyping Assay Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â